Skip to main content
. 2019 Dec 17;56(2):439–447. doi: 10.3892/ijo.2019.4945

Figure 7.

Figure 7

A schematic representation of the anti-cancer effects of OPD' in LNCaP and PC3 cells. RIPK, receptor-interacting serine/threonine-protein kinase; MLKL, mixed lineage kinase domain-like protein; FADD, Fas-associated death domain; FASL, Fas ligand; p, phosphorylated; siRNA, small interfering RNA.